Group One Trading, L.P. Atreca, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.91 - $1.82 $4,550 - $9,100	5,000 New	5,000 $5,000
Q2 2022 Aug 11, 2022	SELL	$1.56 - $3.25 $55,138 - $114,871	-35,345 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.61 - $5.2 $12,368 - $39,946	7,682 Added 27.77%	35,345 $112,000
Q4 2021 Feb 11, 2022	SELL	$2.87 - $6.29 $18,792 - $41,186	-6,548 Reduced 19.14%	27,663 $84,000
Q3 2021 Nov 12, 2021	SELL	$4.91 - $9.07 $29,062 - $53,685	-5,919 Reduced 14.75%	34,211 $213,000
Q2 2021 Aug 10, 2021	BUY	$7.82 - $13.8 $286,000 - $504,707	36,573 Added 1028.2%	40,130 $342,000
Q1 2021 May 12, 2021	BUY	$13.0 - $19.34 $46,241 - $68,792	3,557 New	3,557 $55,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.